SCHEMBL4038003

SCHEMBL4038003

NC(=O)Oc1[nH]c2cccnc2c1Sc1ccccc1C(F)(F)F

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 3/20 0.39
KIF11 P52732 1/20 0.34
KDM4E B2RXH2 1/20 0.34
LMNA P02545 1/20 0.34
MAPT P10636 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
CTNNB1 P35222 1/20 0.33
WNT3A P56704 1/20 0.33
RBP4 P02753 1/20 0.33
TGFBR1 P36897 1/20 0.33
PDE5A O76074 1/20 0.33
HSD11B1 P28845 1/20 0.33
SCD O00767 2/20 0.33
GAA P10253 1/20 0.32
TDP1 Q9NUW8 1/20 0.32
MEN1 O00255 1/20 0.32
TNF P01375 1/20 0.32
CXCL8 P10145 1/20 0.32
KMT2A Q03164 1/20 0.32
PAX8 Q06710 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4041978 0.87 CNR2 (0.35) PARP1KDM4ELMNAMAPTNPSR1
SCHEMBL4214923 0.85 ALDH1A1 (0.37) PARP1KDM4ELMNAMAPTTGFBR1
SCHEMBL4034813 0.84 PKM (0.43) PARP1KDM4ELMNAMAPTNPSR1
SCHEMBL4036107 0.84 PDE5A (0.36) PARP1KDM4ETGFBR1PDE5ATDP1
SCHEMBL2053105 0.83 PARP1 (0.43) PARP1KIF11KDM4ELMNAMAPT
SCHEMBL4041261 0.83 RHEB (0.44) PARP1KDM4ELMNAMAPTNPSR1
SCHEMBL4036257 0.83 TUBB4A (0.43) PARP1KDM4ELMNAMAPTTGFBR1
SCHEMBL4036172 0.83 PDE5A (0.35) PARP1KDM4ETGFBR1PDE5AKMT2A
SCHEMBL4035502 0.82 TUBB4A (0.39) PARP1LMNAPDE5AMEN1KMT2A
SCHEMBL4033284 0.81 PTGS1 (0.37) PARP1KDM4ELMNAPDE5AICAM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1747220-B1 SUBSTITUTED 1H-PYRROLO[3,2-B, 3,2-C, AND 2,3-C]PYRIDINE-2-CARBOXAMIDES AND RELATED ANALOGS AS INHIBITORS OF CASEIN KINASE I EPSILON AVENTIS PHARMA INC (US) 2009-04-15 EP claimed